UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence

Oncogene, 2017-04, Vol.36 (16), p.2255-2264

2017

Volltextzugriff (PDF)

Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials

European journal of cancer (1990), 2019-08, Vol.117, p.91-98

2019

Volltextzugriff (PDF)

Oncologist use and perception of large panel next-generation tumor sequencing

Annals of oncology, 2017-09, Vol.28 (9), p.2298-2304

2017

Volltextzugriff (PDF)

Interhemispheric inhibition in human wrist muscles

Experimental brain research, 2012-09, Vol.221 (4), p.449-458

2012

Volltextzugriff (PDF)

A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer

Breast cancer research and treatment, 2013-07, Vol.140 (2), p.331-339

2013

Volltextzugriff (PDF)

Abstract ES4-1: Longitudinal strategies in ER+ disease

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.ES4-1-ES4-1

Dickler, M

2016

Volltextzugriff (PDF)

When You Look Matters: The Effect of Assessment Schedule on Progression-Free Survival

JNCI : Journal of the National Cancer Institute, 2007-03, Vol.99 (6), p.428-432

2007

Volltextzugriff (PDF)

Menstruation is an unreliable surrogate in the assessment of ovarian damage by chemotherapy: a prospective longitudinal study with AMH levels as the gold standard

Fertility and sterility, 2015-09, Vol.104 (3), p.e262-e263

2015

Volltextzugriff (PDF)

A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer

Annals of oncology, 2011-12, Vol.22 (12), p.2575-2581

2011

Volltextzugriff (PDF)

Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival

Annals of oncology, 2003-07, Vol.14 (7), p.1072-1077

2003

Volltextzugriff (PDF)

The impact of long-term tamoxifen treatment on ovarian reserve markers in women with breast cancer: a prospective-longitudinal study

Fertility and sterility, 2013-09, Vol.100 (3), p.S64-S64

2013

Volltextzugriff (PDF)

A prospective longitudinal study of the impact of breast cancer chemotherapy on ovarian reserve: do individuals have differing susceptibilities?

Fertility and sterility, 2014-09, Vol.102 (3), p.e151-e151

2014

Volltextzugriff (PDF)

Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer

Breast cancer research and treatment, 2008-09, Vol.111 (2), p.377-388

2008

Volltextzugriff (PDF)

Germline BRCA1 gene mutations result in accelerated ovarian aging: a translational study

Fertility and sterility, 2012-09, Vol.98 (3), p.S24-S24

2012

Volltextzugriff (PDF)

Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans

Science translational medicine, 2013-02, Vol.5 (172), p.172ra21

2013

Volltextzugriff (PDF)

Immunogenicity of a Fucosyl-GM1-Keyhole Limpet Hemocyanin Conjugate Vaccine in Patients with Small Cell Lung Cancer

Clinical cancer research, 1999-10, Vol.5 (10), p.2773-2779

1999

Volltextzugriff (PDF)

Maximizing the Potential of Bevacizumab in Cancer Treatment

The oncologist (Dayton, Ohio), 2004-06, Vol.9 (S1), p.36-42

2004

Volltextzugriff (PDF)

PP 66 Utility of VEGF and IL-6 as biomarkers for response to PTC299, a novel antiangiogenic

European journal of cancer (1990), 2011, Vol.47, p.S15-S15

2011

Volltextzugriff (PDF)

Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

Journal of clinical oncology, 2005-02, Vol.23 (4), p.792-799

2005

Volltextzugriff (PDF)

The MORE trial: multiple outcomes for raloxifene evaluation--breast cancer as a secondary end point: implications for prevention

Annals of the New York Academy of Sciences, 2001-12, Vol.949 (1), p.134-142

2001

Volltextzugriff (PDF)

Increased chemotherapy-induced ovarian reserve loss in women with BRCA mutations: a prospective longitudinal study with mechanistic confirmation

Fertility and sterility, 2018-09, Vol.110 (4), p.e430-e430

2018

Volltextzugriff (PDF)

Abstract P6-12-12: Improvement in sexual function over time in premenopausal women with breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P6-P6-12-12

2018

Volltextzugriff (PDF)

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer

Clinical breast cancer, 2018-10, Vol.18 (5), p.387-394

2018

Volltextzugriff (PDF)

026 Factors Influencing Sexual Function and Its Trajectory Throughout Treatment and Survivorship in Premenopausal Women with Breast Cancer

Journal of sexual medicine, 2018-06, Vol.15 (6), p.S108-S108

2018

Volltextzugriff (PDF)

Abstract P4-11-06: Feasibility of a non-hormonal vaginal moisturizer in postmenopausal cancer survivors

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P4-P4-11-06

2016

Volltextzugriff (PDF)

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(216)

Publikationsform

Sprache

Englisch
(240)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(86)
Humans
(70)
Female
(55)
Oncology
(46)
Middle Aged
(36)
Adult
(35)
Aged
(30)
Biological And Medical Sciences
(28)
Breast Neoplasms - Drug Therapy
(23)
Breast Cancer
(22)
Breast Neoplasms - Pathology
(21)
Male
(21)
Medical Sciences
(21)
Tumors
(16)
Animals
(13)
Aged, 80 And Over
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
B-Lymphocytes - Immunology
(12)
Antineoplastic Agents
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence

Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials

Oncologist use and perception of large panel next-generation tumor sequencing

Interhemispheric inhibition in human wrist muscles

A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer

Abstract ES4-1: Longitudinal strategies in ER+ disease

When You Look Matters: The Effect of Assessment Schedule on Progression-Free Survival

Menstruation is an unreliable surrogate in the assessment of ovarian damage by chemotherapy: a prospective longitudinal study with AMH levels as the gold standard

A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer

Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival

The impact of long-term tamoxifen treatment on ovarian reserve markers in women with breast cancer: a prospective-longitudinal study

A prospective longitudinal study of the impact of breast cancer chemotherapy on ovarian reserve: do individuals have differing susceptibilities?

Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer

Germline BRCA1 gene mutations result in accelerated ovarian aging: a translational study

Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans

Immunogenicity of a Fucosyl-GM1-Keyhole Limpet Hemocyanin Conjugate Vaccine in Patients with Small Cell Lung Cancer

Maximizing the Potential of Bevacizumab in Cancer Treatment

PP 66 Utility of VEGF and IL-6 as biomarkers for response to PTC299, a novel antiangiogenic

Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

The MORE trial: multiple outcomes for raloxifene evaluation--breast cancer as a secondary end point: implications for prevention

Increased chemotherapy-induced ovarian reserve loss in women with BRCA mutations: a prospective longitudinal study with mechanistic confirmation

Abstract P6-12-12: Improvement in sexual function over time in premenopausal women with breast cancer

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer

026 Factors Influencing Sexual Function and Its Trajectory Throughout Treatment and Survivorship in Premenopausal Women with Breast Cancer

Abstract P4-11-06: Feasibility of a non-hormonal vaginal moisturizer in postmenopausal cancer survivors

Suchergebnisse filtern